investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of Angiogenesis Inhibitors

William Figg

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Neil Vargesson

University of Aberdeen

Aberdeen, United Kingdom

Related projects

Paul Tempst

Immobilized protease activity tests for developing functional cancer biomarkers.

Prostate

Mirit Aladjem

Initiation of DNA Replication in Mammalian Cells

All cancers but non-melanoma skin cancer

Jordan Scott Orange

Directing Function at the Natural Killer Cell Secretory Immunological Synapse

All cancers but non-melanoma skin cancer

Brigitte Widemann

Therapies for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes

All cancers but non-melanoma skin cancer

Ekaterina Pletneva

Conformational Properties of Cytochrome c in Apoptosis

All cancers but non-melanoma skin cancer

Wei-Shau Hu

Understanding Retroviral Gag and RNA Targeting and Virus Assembly

All cancers but non-melanoma skin cancer

David Roberts

Roles of Glycoconjugates and Redox Signaling in Tumor Biology – Rockville

All cancers but non-melanoma skin cancer

Radiation Oncology

Pengda Liu

Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy

Prostate

Damien Garbett

Identification of mechanisms involved in coordinated group migration

All cancers but non-melanoma skin cancer